Efficacy and safety of daclatasvir and asunaprevir for hepatitis C virus genotype 1b infection
Author:
Publisher
The Korean Association for the Study of the Liver
Subject
Molecular Biology,Hepatology
Link
http://e-cmh.org/upload/pdf/cmh-2016-0020.pdf
Reference33 articles.
1. Treatment of hepatitis C
2. Diagnosis, management, and treatment of hepatitis C: An update
3. Global epidemiology and genotype distribution of the hepatitis C virus infection
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection;Clinical and Molecular Hepatology;2019-12-25
2. Real‐life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance‐associated substitution test;Journal of Medical Virology;2019-09-09
3. Clinical outcomes after the introduction of direct antiviral agents for patients infected with genotype 1b hepatitis C virus depending on the regimens: A multicenter study in Korea;Journal of Medical Virology;2019-02-11
4. Pharmacokinetic and pharmacodynamic evaluation of daclatasvir, asunaprevir plus beclabuvir as a fixed-dose co-formulation for the treatment of hepatitis C;Expert Opinion on Drug Metabolism & Toxicology;2018-06-03
5. Early development of de novo hepatocellular carcinoma after direct-acting agent therapy: Comparison with pegylated interferon-based therapy in chronic hepatitis C patients;Journal of Viral Hepatitis;2018-05-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3